On 1 January 20X1, Cartéo acquired mapping software for 300,000, amortised on a straight-line basis over 6 years with no residual value. At the year-end review at 31 December 20X2, after recognising the 20X2 charge, management concludes that a change in technical standards will make the software unusable at the end of 20X4: the remaining useful life is now only 2 years. The finance director proposes to restate 20X1 and 20X2 over a total life of 4 years. Which treatment should be adopted?
Single choiceAdvancedPublished